Abhishek Kumar Singh Selected Research

Abhishek Kumar Singh Research Topics

Disease

4	Type 2 Diabetes Mellitus (MODY) 01/2022 - 10/2014
4	Inflammation (Inflammations) 01/2021 - 06/2017
4	Breast Neoplasms (Breast Cancer) 10/2014 - 12/2013
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 11/2021 - 01/2016
3	Infections 01/2021 - 01/2011
3	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 10/2017
3	Metabolic Bone Diseases (Osteopenia) 11/2018 - 07/2015
3	Neoplasms (Cancer) 10/2016 - 04/2012
2	Neuroinflammatory Diseases 01/2021 - 02/2019
2	Body Weight (Weight, Body) 09/2020 - 10/2017
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2020 - 02/2019
2	Parkinson Disease (Parkinson's Disease) 01/2020 - 01/2019
2	Wounds and Injuries (Trauma) 05/2017 - 12/2016
1	Depressive Disorder (Melancholia) 01/2022
1	Major Depressive Disorder (Major Depressive Disorders) 01/2022
1	Pain (Aches) 01/2022
1	Insulin Resistance 01/2022
1	Fever (Fevers) 01/2022
1	Hypertrophy 10/2021
1	Leishmaniasis 01/2021
1	Asymptomatic Infections 01/2021
1	Visceral Leishmaniasis (Kala Azar) 01/2021
1	Amyloid Plaque 01/2020
1	Leprosy (Hansen's Disease) 01/2020
1	Leukemia 01/2020
1	Hypoxia (Hypoxemia) 01/2020
1	Atypical Hemolytic Uremic Syndrome 01/2019
1	Necrosis 05/2018
1	Myeloid Leukemia (Leukemia, Myelocytic) 10/2017
1	Neuroblastoma 10/2017
1	Hyperglycemia 06/2017
1	Starvation 01/2017
1	Muscular Atrophy (Muscle Atrophy) 01/2017
1	Atrophy 01/2017
1	Wound Infection (Wound Infections) 12/2016
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2016
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2016
1	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 04/2016
1	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2016

Drug/Important Bio-Agent (IBA)

5	Pharmaceutical PreparationsIBA 01/2022 - 01/2016
4	Metformin (Glucophage)FDA LinkGeneric 10/2017 - 07/2015
3	AdiponectinIBA 01/2022 - 10/2014
3	AntioxidantsIBA 01/2021 - 06/2017
3	Sirolimus (Rapamycin)FDA Link 02/2019 - 10/2017
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2022 - 01/2021
2	NitritesIBA 01/2022 - 10/2017
2	LipidsIBA 09/2020 - 10/2014
2	Clofazimine (Lamprene)FDA Link 01/2020 - 01/2016
2	SynucleinsIBA 01/2020 - 01/2019
2	Amyloid (Amyloid Fibrils)IBA 01/2020 - 10/2017
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2016
2	Investigational DrugsIBA 11/2018 - 03/2016
2	odanacatibIBA 11/2018 - 03/2016
2	Estrogens (Estrogen)FDA Link 11/2018 - 03/2016
2	Alendronate (Alendronate Sodium)FDA LinkGeneric 11/2018 - 03/2016
2	BiguanidesIBA 06/2017 - 02/2017
2	Adiponectin ReceptorsIBA 01/2017 - 07/2015
2	CytokinesIBA 01/2017 - 01/2016
2	Histamine Receptors (Histamine Receptor)IBA 10/2016 - 05/2014
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2022
1	Phenol (Carbolic Acid)FDA Link 01/2022
1	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2022
1	Estrogen ReceptorsIBA 01/2022
1	Phosphotransferases (Kinase)IBA 11/2021
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 10/2021
1	Galactose (Galactopyranose)FDA LinkGeneric 01/2021
1	Free RadicalsIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 09/2020
1	Imatinib Mesylate (Gleevec)FDA Link 01/2020
1	Trans-Activators (Trans-Acting Factor)IBA 01/2020
1	gamma-glutamylaspartic acidIBA 01/2020
1	STAT5 Transcription FactorIBA 01/2020
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2020
1	ubiquitin-aldehydeIBA 01/2020
1	Deubiquitinating EnzymesIBA 01/2020
1	Annexin A5IBA 01/2020
1	Pioglitazone (Actos)FDA Link 01/2020
1	Complement Factor H (Factor H)IBA 01/2019
1	Beclin-1IBA 05/2018
1	InterleukinsIBA 05/2018
1	Synapsins (Synapsin I)IBA 05/2018
1	Phosphopyruvate Hydratase (Enolase)IBA 05/2018
1	Tumor Biomarkers (Tumor Markers)IBA 05/2018
1	fisetinIBA 01/2018
1	Nitric Oxide Synthase (NO Synthase)IBA 10/2017
1	Amyloid beta-PeptidesIBA 10/2017
1	Hypoglycemic Agents (Hypoglycemics)IBA 06/2017
1	ChitosanIBA 05/2017
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2017
1	SteroidsIBA 01/2017
1	HydrogelsIBA 12/2016
1	Ointments (Pastes)IBA 12/2016
1	Plant ExtractsIBA 12/2016
1	ErbB Receptors (EGF Receptor)IBA 10/2016
1	Gefitinib (Iressa)FDA Link 10/2016
1	oxidized low density lipoproteinIBA 04/2016
1	DiamideIBA 01/2016

Therapy/Procedure

2	Aftercare (After-Treatment) 01/2021 - 09/2020
2	Therapeutics 01/2017 - 12/2013
1	Caloric Restriction 02/2017